Birth Defects following Levetiracetam Use in Pregnancy – A Case Report

Abstract

There is a lack of substantial data on the safety of Levetiracetam during pregnancy in the context of the potential teratogenic effect on the newborn. We report a probable case of levetiracetam birth defects in a newborn with multiple congenital anomalies.